1.
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING...
by Cahn, Pedro, Dr
The Lancet (British edition), 2013, Vol.382 (9893), p.700-708
2.
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected...
by Molina, Jean-Michel, Prof
The Lancet (British edition), 2008, Vol.372 (9639), p.646-655
Filter electronic articles 2 Hits
Remove Filters
- Journal Title
- The Lancet
- Middle Aged (2)
- Viral Load (2)
- Human Immunodeficiency Virus (2)
- Internal Medicine (2)
- Drug Administration Schedule (2)
- Hiv-1
- Female (2)
- Drug Therapy (2)
- Hiv
- Hiv Infections - Drug Therapy (2)
- Drug Dosages (1)
- Drug Resistance, Viral (1)
- Double-Blind Method (1)
- Aged (1)
- Antiretroviral Drugs (1)
- Atazanavir Sulfate (1)
- Clinical Medicine (1)
- less ...